利妥昔单抗治疗非亲缘脐血干血细胞移植后并发免疫性血小板减少症1例报道(英文)

查看全文 作　　者：Mengxing [1]Li;Jishi [1]Wang;Yan [1]Zhang;Zhiqiang [1]Sun;Yanju [1]Li;Xiaoli [1]Zhou

机构地区：[1]Department of Hematology,The Affiliated Hospital of Guiyang Medical College

出　　处：《The Chinese-German Journal of Clinical Oncology》索引2013年第12卷第6期,共3页

摘　　要：Immune thrombocytopenia (ITP) is a chronic disease resulting from increased platelet destruction and impaired platelet production. Secondary ITP can be a manifestation of chronic graft-versus-host disease (GVHD) and represent a lymphoproliferative disorder. A boy with chronic graft-versus-host disease after cord blood stem cell transplantation who had severe refractory immune-mediated thrombocytopenia received infusion of rituximab weekly, 375 mg/m2, for 4 weeks. Platelets count of the patient was recovered, and rituximab was well tolerated with no severe toxicity observed during treatment. 关键词：肿瘤临床治疗化疗

相关文献

参考文献（11）
引证文献（0）
耦合文献（17）

参考文献(11)

耦合文献(17)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

利妥昔单抗治疗非亲缘脐血干血细胞移植后并发免疫性血小板减少症1例报道(英文)

参考文献(11)

耦合文献(17)

用户提示